Clinical Trial: A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018453) titled 'A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs' on June 05.

Brief Summary: The purpose of this study is to evaluate the glycemic control and safety of SHR-3167 and Insulin Degludec in type 2 diabetic participants treated with basal insulin with or without oral antidiabetic drugs.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus

Intervention: DRUG: SHR-3167

SHR-3167 Injection.

DRUG: Insulin Degludec

Insulin Degludec Injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu Heng...